Masood Masoodian is an Associate Professor in the Department of Art and Media at Aalto University, Finland. He leads the Visual Communication Design research group, focusing on interactive visualization for health, energy, and sustainability contexts. Previously, he held roles at the University of Waikato (2000-2016), University of Southern Denmark, and Massey University. Education: Doctoral degree in Other disciplines from the University of Waikato (1999) Research interests include design thinking, visualization of complex data, and creative aging interventions. Notable projects include the EU-funded INT-ACT initiative (2024-2026) addressing intangible cultural heritage. He has received an award for collaborative work on video game ludonarrative analysis (2019). Recent activities include organizing workshops on map-based interfaces, co-creating cultural heritage methods, and delivering public talks on digital design. Supervised two theses and contributed to 131 peer-reviewed outputs, emphasizing human-centered design and sustainability. Grants: Principal investigator for multiple EU projects totaling over 3 years of active funding. Awards: Prize for 'Comedy in the Ludonarrative of Video Games' (2019). Labs/Teams: Visual Communication Design group, collaborating internationally on projects like INT-ACT's cultural heritage mapping.
Angel Xuan Chang is an Associate Professor at Simon Fraser University's School of Computing Science, where she leads research at the intersection of natural language processing, computer vision, and 3D scene understanding. She holds the prestigious Canada CIFAR AI Chair position and is affiliated with multiple research groups including 3DLG, GrUVi, SFU NatLang, SFU AI/ML, and VINCI. PhD in Computer Science, Stanford University MSc in Computer Science, Stanford University M.Eng in Electrical Engineering and Computer Science, MIT BSc in Computer Science and Engineering, MIT Professor Chang's research primarily focuses on connecting language to 3D representations of shapes and scenes, with particular emphasis on grounding language for embodied agents in indoor environments. Her work spans natural language processing and understanding, linking natural language with visual and 3D representations, multimodal grounding of language, embodied AI, and machine learning applications for biodiversity monitoring through the BIOSCAN project. She has developed methods for synthesizing 3D scenes and shapes from natural language and created various datasets for 3D scene understanding. Her recent publications reveal a strong trend toward integrating language understanding with 3D scene generation and manipulation, with increasing focus on practical applications in embodied AI and biodiversity monitoring. The research shows progression from foundational work on text-to-3D scene generation to more sophisticated approaches for evaluating semantic coherence in generated scenes and developing efficient methods for zero-shot scene modeling. Canada CIFAR AI Chair TUM-IAS Hans Fischer Fellow (2018-2022) Best paper award at 3DV 2025 for 'An Object is Worth 64x64 Pixels: Generating 3D Object via Image Diffusion' Professor Chang actively advises numerous graduate students who appear as first authors on her publications, indicating a strong mentoring program. Her research is supported through multiple channels including the CIFAR AI Chair position and likely various research grants supporting her BIOSCAN-related work and 3D scene understanding projects. She has been involved in organizing multiple workshops at major conferences including ICML, CVPR, and ICLR. Her research is conducted through several interconnected groups: 3DLG (3D Language and Graphics), GrUVi (Graphics, Vision, and Interaction), SFU NatLang (Natural Language Processing), SFU AI/ML, and VINCI. These groups work collaboratively on problems spanning language grounding, 3D scene understanding, embodied AI, and biodiversity applications, creating a rich interdisciplinary research environment.
Dr. Michael Baym is an Associate Professor of Biomedical Informatics at Harvard Medical School with affiliate appointments in Microbiology and the Laboratory of Systems Pharmacology, and as an Associate Member of the Broad Institute. He leads the Baym Lab, which studies microbial evolutionary genomics and antibiotic resistance through a hybrid of experimental, computational, and theoretical approaches. His research focuses on: Antibiotic Resistance Evolution and practical interventions Mobile Genetic Elements (plasmids, phages, transposons) Computational Genomic Algorithms for big data analysis Synthetic Biology tools and technologies Key recent publications explore phage discovery systems , phylogenetic compression of microbial genomes, and RNA-guided gene drives in plasmids. His work is supported by multiple NIH/NIGMS and NSF grants including a MIRA award. Scientific honors include: Packard Fellowship (2018) Pew Biomedical Scholarship (2020) Sloan Research Fellowship (2020) A. Clifford Barger Excellence in Mentoring Award (2021) SSQBio Mentorship Award (2022) The lab actively trains PhD students and postdoctoral fellows with alumni occupying academic and industry positions globally. Current team members include researchers from interdisciplinary backgrounds working at the intersection of experiment, computation, and theory .
Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.
Dana Pe'er is a Professor and Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute (SKI) of Memorial Sloan Kettering Cancer Center. She is also an Investigator of the Howard Hughes Medical Institute and holds the Alan and Sandra Gerry Endowed Chair. Dr. Pe'er leads an interdisciplinary research group that combines advanced genomics approaches with machine learning to address fundamental questions in biomedical science, with particular focus on cancer biology, developmental biology, and immunology. Dr. Pe'er earned her PhD from Hebrew University in Jerusalem, Israel. Her academic journey includes a postdoctoral fellowship with George Church at Harvard Medical School. Before joining Memorial Sloan Kettering Cancer Center in 2016, she held faculty positions at Columbia University. Dr. Pe'er's research focuses on understanding cellular plasticity, the consequences of intra-tumor heterogeneity, cancer evolution and metastasis, and the mechanisms by which regulatory circuits go awry in disease. Her lab combines single-cell and spatial profiling technologies with machine learning approaches to investigate gene regulation, cellular plasticity, and cell-cell communication in the contexts of cancer, immunity, and development. They are particularly interested in how organisms develop from a single cell to generate diverse cell types, how epigenetic control rewires during development, and how cells communicate to execute multicellular responses. Analysis of Dr. Pe'er's recent publications reveals a strong focus on developing computational methods for single-cell and spatial genomics data analysis. Her work spans cancer types including pancreatic, prostate, colorectal, and breast cancer, with emphasis on tumor heterogeneity, metastasis mechanisms, and cellular plasticity. A significant portion of her research involves creating novel algorithms and tools like CellRank, REUNION, and SEACells that enable researchers to extract meaningful biological insights from complex genomic datasets. 2023 Class of 2023 Inductee - American Academy of Cancer Research (AACR) Academy 2023 Innovator Award - International Society for Computational Biology (ISCB) 2021 Fellow - International Society for Computational Biology (ISCB) Howard Hughes Medical Institute Investigator (2021) 2019 Ernst W. Bertner Memorial Award - University of Texas MD Anderson Cancer Center 2016 Lenfest Distinguished Faculty Award - Columbia University 2014 Director's Pioneer Award - National Institutes of Health 2014 Overton Prize - International Society for Computational Biology (ISCB) Dr. Pe'er is known for her dedicated mentorship approach, describing herself as "a mama bear" who cares deeply about her trainees while expecting independence, innovation, and hard work. She mentors numerous PhD students and postdocs in her lab. Her HHMI Investigator award provides approximately $9 million over seven years, enabling ambitious research directions. She also collaborates extensively with the Single-cell Analytics and Innovation Lab (SAIL) at MSK to generate new data from emerging technologies, working closely with wet-lab collaborators at MSK and beyond to apply computational methods to cutting-edge datasets across multiple disease areas. The Pe'er Lab is an interdisciplinary group of computational biologists with diverse backgrounds ranging from pure mathematics to clinical medicine. They work closely with wet-lab collaborators to apply their computational methods to cutting-edge datasets across cancer, immunology, and developmental biology. The lab is described as open, supportive, collaborative, and fun, with access to world-class facilities at the Sloan Kettering Institute. Dr. Pe'er's work continues to push the boundaries of computational biology and cancer research, with the ultimate goal of developing more effective, personalized therapies for cancer patients.
Dr. Pamela D. Roberts is a Professor of Plant Pathology and State Extension Specialist for Vegetable Pathology at the University of Florida's Southwest Florida Research and Education Center (SWFREC) in Immokalee, FL. She holds a B.Sc. in Horticultural Sciences from Kansas State University, an M.S. in Plant Pathology from the University of Hawaii, and a Ph.D. in Plant Pathology from the University of Florida. Her research focuses on sustainable disease management in vegetables and specialty crops, emphasizing integrated management strategies for bacterial and fungal-like pathogens. She leads the Florida Extension Plant Disease Diagnostic Laboratory at SWFREC, offering diagnostic services and disease management recommendations. Her extension programs include educational outreach on plant diseases and field demonstrations of integrated management techniques. Dr. Roberts has received prestigious awards such as the UF/IFAS Jim App Team Award and the Dallas Townsend Distinguished Extension Award. She serves as Editor-in-Chief of the American Phytopathological Society journal Plant Health Progress . Her work spans disease diagnosis, epidemiology, and pathogen evolution, with a strong emphasis on crops like tomato, pepper, and citrus. Her research publications address topics such as Xanthomonas pathogen diversity, remote sensing for disease detection, and sustainable agricultural practices. She collaborates on projects involving molecular diagnostics, pest management strategies, and crop resilience. Ongoing efforts include combating bacterial spot diseases, whitefly-transmitted viruses, and citrus black spot.
Jens S. Andersen is a Professor in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, where he leads research in Biomedical Mass Spectrometry and Systems Biology. His work is centered on the development and application of quantitative mass spectrometry and microscopy-based proteomics to study human cell biology, particularly the structure and function of organelles such as centrosomes, cilia, autophagosomes, and mitochondria. His research focuses on determining the protein composition and dynamic properties of cellular organelles, the roles of specific protein groups, and their contributions to biological processes and diseases. He investigates cell signaling mediated by post-translational modifications, especially within the DNA damage response, autophagy, and immune systems. His lab, the Jens S. Andersen Lab, is part of the Research Section of Biomedical Mass Spectrometry. The analysis of his recent publications reveals a strong interdisciplinary trend combining proteomics, structural biology, and cell signaling. His work spans cilia biology, RNA metabolism, DNA repair, and cancer mechanisms, with frequent use of advanced techniques like mass spectrometry, CRISPR, and live-cell imaging. The integration of systems biology approaches is evident across his research outputs. Professor, Department of Biochemistry and Molecular Biology, University of Southern Denmark Head of Research, Biomedical Mass Spectrometry and Systems Biology Principal Investigator, Jens S. Andersen Lab ORCID: 0000-0002-6091-140X While no specific scientific awards are mentioned in the provided texts, his extensive publication record in high-impact journals such as Science , Nature Communications , Molecular Cell , and EMBO Journal reflects significant scholarly contributions. He has supervised research projects and collaborated widely across Europe, though specific names of students are not listed. His research is supported by multiple ongoing projects, reflecting sustained funding and academic leadership. The Jens S. Andersen Lab operates at the intersection of proteomics and cell biology, contributing to fundamental understanding of organelle dynamics and disease mechanisms. The lab's work is highly collaborative, involving partnerships with groups in structural biology, RNA research, and cancer biology.
Yousif Shamoo is the Ralph and Dorothy Looney Professor of BioSciences at Rice University, where he has been a faculty member since 1998. He previously served as Vice Provost for Research (2014-2022) and Director of the Institute of Biosciences and Bioengineering (2008-2014). He holds a Ph.D. in Molecular Biophysics and Biochemistry from Yale University (1988). His research focuses on combating multi-drug resistant bacteria through experimental evolution and biophysical approaches. Key interests include: Evolutionary trajectories of antibiotic resistance in pathogens like Enterococcus and Acinetobacter Biochemical basis of adaptation using microfluidics, genomics, and structural biology Discovery of novel antimicrobial strategies targeting cell membrane stress pathways Microbial interactions in spatially structured environments Publications emphasize antimicrobial resistance mechanisms, evolutionary biophysics, and microfluidic technology development. Recent work explores daptomycin resistance pathways ( LiaFSR ), membrane lipid signaling, and high-throughput evolution platforms. Awards & Honors: AAAS Fellow (2024) Ralph and Dorothy Looney Professorship (2020) George R. Brown Award for Excellence in Teaching (2015) George R. Brown Superior Teaching Award (4×, 2009 onward) ASM Distinguished Lecturer (2011-2013) He leads an active research group funded by NIH and DoD, advising 15+ graduate students. Current projects integrate synthetic biology with Streptomyces-derived drug discovery and microfluidic biosurveillance platforms.
Dr. Gabriele Schweikert is a Senior Lecturer and Principal Investigator with a joint appointment between the Division of Computational Biology in the School of Life Sciences at University of Dundee and Cyber Valley in Tuebingen. Her research focuses on applying machine learning techniques to understand epigenetic mechanisms and molecular processes in living cells. Dr. Schweikert completed her PhD at the Max Planck Institute Tuebingen working with Schoelkopf, Weigel, and Raetsch labs on machine learning for computational gene finding. She subsequently joined Adrian Bird's lab at the Wellcome Trust Center for Cell Biology in Edinburgh, a pioneer in epigenomic research. Prior to her current position, she held prestigious Marie Curie and EMBO Fellowships at the School of Informatics, University of Edinburgh. Her research interests center on using machine learning to decode epigenetic mechanisms that determine cellular identity and function. She investigates how cells with identical DNA can differentiate into specialized cell types through epigenetic regulation, with particular focus on applications in understanding tumorigenesis where epigenetic machinery malfunctions. Her work combines high-throughput epigenomic data with advanced computational approaches to address complex biological questions. Analysis of her recent publications reveals a strong focus on epigenomic data analysis, machine learning applications in biology, and computational approaches to understanding gene regulation. Her work spans from fundamental epigenetic mechanisms to practical applications in disease research, with growing emphasis on individual-specific epigenomic analysis and explainable AI in biomedical contexts. UKRI Future Leaders Fellowship (2020, £1.6 million) Marie Curie Fellowship EMBO Fellowship Dr. Schweikert actively supervises PhD students and has received significant research funding for projects including 'Machine Learning Methods to Re-Annotate Histone Modifications,' 'Unlocking The Alternative Splicing Code,' and 'GPU-Based Machine Learning System For Fundamental Biological Research.' She is involved in multiple interdisciplinary collaborations and frequently presents her work at major conferences including ELLIS Health program retreat, Epigenetics Meetings, and RECOMB workshops. She maintains active research laboratories in both Dundee and Tuebingen, fostering international collaboration between computational biologists, machine learning experts, and experimental biologists to advance our understanding of epigenetic regulation in health and disease.
Nasir M. Rajpoot is a Professor in the Department of Computer Science at the University of Warwick, UK. His research focuses on computational pathology, medical image analysis, and deep learning applications in histology. He leads interdisciplinary projects integrating artificial intelligence with healthcare, particularly in cancer diagnostics and pathology workflows. Rajpoot’s work emphasizes developing robust algorithms for histology image analysis, including nuclear segmentation, tumor classification, and domain generalization in computational pathology. His contributions include the TIAToolbox, an open-source framework for tissue image analytics, and the CoNIC Challenge to advance nuclear detection and counting in histology images. He collaborates with clinicians and biologists to translate AI models into clinical practice, addressing challenges like tumor heterogeneity and staining variability. Rajpoot’s research spans colorectal, lung, and oral cancers, with a focus on predicting clinical outcomes via histological features and genomic data integration. Notable projects include the development of Handcrafted Histological Transformer (H2T) for unsupervised representations of whole slide images and the SAFRON framework for histology image synthesis. His work addresses domain adaptation, robustness evaluation, and explainability in AI-driven pathology systems.
Michael Z. Levy is a Professor of Epidemiology in the Department of Biostatistics and Epidemiology at the University of Pennsylvania Perelman School of Medicine. He co-directs the University of Pennsylvania/Universidad Peruana Cayetano Heredia Zoonotic Disease Research Laboratory in Arequipa, Peru, and holds secondary affiliations with the Center for Clinical Epidemiology and Biostatistics, Center for Public Health Initiatives, History and Sociology of Science, and Latin American and Latinx Studies. His research spans interdisciplinary domains including vector-borne diseases, computational biology, urban ecology, and social justice. Education: B.A. in Philosophy and Biology from Amherst College (1998), PhD in Population Biology, Ecology, and Evolution from Emory University (2007). Levy's work focuses on urban zoonotic diseases , particularly Chagas disease and canine rabies , integrating ecology, epidemiology, and computational methods. He investigates how insect vectors interact with social systems, housing policies, and climate change, extending to pandemic modeling during the Covid-19 crisis. His research group (28 members) collaborates with Peruvian Ministry of Health to control Chagas and rabies outbreaks in Arequipa. Notable contributions include novel geospatial surveillance models , behavioral economics applications for vector control, and bed bug epidemiology linking infestations to public health challenges. Recent publications highlight 2025-2024 trends in Chagas vector dynamics , zoonotic rabies control , vaccine strategies , and genomic outbreak analysis , emphasizing interdisciplinary approaches to urban disease ecology. He has participated in cluster randomized trials and behavioral design studies to improve community engagement in vector control campaigns in Peru, focusing on incentive mechanisms and surveillance equity . The Zoonotic Disease Research Lab in Arequipa employs interdisciplinary methods combining biological research , social science , and computational modeling to address urban disease transmission.
Max Lau is an Assistant Professor in the Department of Biostatistics and Bioinformatics and the Department of Epidemiology at Emory University. His research focuses on integrating machine learning and computational methods with epidemiological and genomic data to study infectious disease dynamics. He teaches courses such as BIOS 790R (Advanced Seminar in Biostatistics) and DATA 534 (Applied Machine Learning). Dr. Lau's work emphasizes scalable Bayesian inference, graph neural networks, and stochastic modeling to address challenges in disease transmission, outbreak control, and pathogen evolution. His recent research includes developing tools like ScITree and Epilearn, and he has contributed to understanding measles dynamics, tuberculosis treatment, and livestock disease management. His academic contributions span over 30 publications since 2010, with a particular focus on phylodynamics, epidemic modeling, and vaccine strategy evaluation. His interdisciplinary approach bridges computational methods with public health applications, aiming to enhance disease prediction and intervention efficacy.
Dr. Rong Fan is the Harold Hodgkinson Professor of Biomedical Engineering and Professor of Pathology at Yale University. His research focuses on developing and applying single-cell and spatial omics technologies to study immune systems, cancer, and aging. His lab has pioneered technologies like the IsoCode microchip for high-throughput protein profiling, and spatial multi-omics platforms (e.g., DBiT-seq, spatial-ATAC-seq) to analyze tissue complexity at cellular resolution. He co-founded IsoPlexis, Singleron Biotechnologies, and AtlasXomics to commercialize these innovations. Education: PhD in Chemistry from UC Berkeley (2006), B.S. in Applied Chemistry from University of Science and Technology of China (1999). Postdoctoral training at Caltech before joining Yale in 2010. Research interests include CAR-T cell therapy optimization, spatial epigenomics, and multi-omics integration. Key achievements include discovering biomarkers predictive of CAR-T efficacy and defining spatial genomic landscapes in cancer and neuroinflammation. Awards: NSF CAREER Award, Packard Fellowship, election to AIMBE, CASE, and NAI. Serves on advisory boards for Bio-Techne and Yale Ventures. Active in training future scientists via the Yale Biomedical Engineering and Yale School of Medicine programs.
Richard DUNCAN is a Professor in Conservation Biology at the University of Canberra's Science School and Department of Centre for Conservation and Ecology Genetics. His research focuses on the ecology of invasive species, particularly understanding how introduced species arrive, establish, and spread in new environments. Key areas include invasive weeds and pests, ecological community structure, and applying quantitative methods to address both fundamental and applied ecological questions. Education: PhD in Forest Ecology, University of Canterbury (1989, award date noted as 2024 in text) Research Interests: His work spans invasive species ecology, population dynamics, and restoration strategies. He employs diverse methods including field experiments, modeling, and genomics, with recent focus on grasslands and aquatic systems. Current projects address amphibian chytrid fungus, carp invasions, and rodent control. Articles Trends: Recent publications emphasize invasive species impacts on ecosystems, pathogen-driven niche contractions, and conservation tools like geospatial modeling and genomic simulations. Themes include species distribution modeling, pest management, and restoration ecology. Awards & Grants: Lead investigator on 35+ projects, including ARC Plant Biosecurity Training Centre and chytrid fungus mitigation efforts Associate Editor for Proceedings of the Royal Society B and Diversity and Distributions Advising: Accepting PhD students in invasive species ecology, with focus on using biological invasions to explore ecological theory and management applications. Labs/Teams: Collaborates widely on conservation genetics, aquatic invasions, and biosecurity, including work with the Biological Heritage Science Challenge and Indigenous Grasslands Trust.
Vitaly Kheyfets, PhD, serves as Associate Professor in the Department of Pediatrics-Critical Care Medicine at the University of Colorado Anschutz Medical Campus School of Medicine, where he directs research at the intersection of pediatric critical care and cardiopulmonary pathophysiology with emphasis on pulmonary arterial hypertension (PAH). His primary research focuses on right ventricular adaptation to pulmonary hypertension, utilizing machine learning-driven multi-omics analysis to identify disease biomarkers and molecular networks. He pioneers computational fluid dynamics approaches for hemodynamic modeling in congenital heart conditions like Glenn physiology, while also investigating sleep oscillatory patterns as neurodegenerative biomarkers. His methodology integrates proteomics, spatial transcriptomics, and pressure waveform analysis to dissect vascular remodeling mechanisms. Publication trends reveal a strong emphasis on translating computational models into clinical applications for PAH prognostication, with recent work developing AI-cooperative diagnostic platforms and characterizing microvascular changes in the right ventricle. Cross-disciplinary collaborations span proteomics, imaging, and sleep neuroscience, demonstrating consistent innovation in both pulmonary hypertension and neurodegenerative disease biomarker discovery.
